Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 10,583 | 270 | 146 | N/A |
| Marketable Securities | 22,028 | N/A | N/A | N/A |
| Receivables | 274 | 29 | 10 | N/A |
| TOTAL | $32,885 | $299 | $156 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 60 | 2 | N/A | N/A |
| Investments And Advances | 9 | 5 | 0 | 0 |
| TOTAL | $69 | $7 | $N/A | $N/A |
| Total Assets | $32,954 | $306 | $156 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,280 | 131 | 81 | 0 |
| TOTAL | $2,280 | $131 | $81 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,280 | $131 | $81 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 39 | 24 | 20 | N/A |
| Retained earnings | -8,422 | -1,400 | -229 | N/A |
| TOTAL | $30,674 | $175 | $75 | $N/A |
| Total Liabilities And Equity | $32,954 | $306 | $156 | $0 |